Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hybribio
Chaozhou, Guangdong, China
- Ownership
- Private
- Employees
- ~180
- Development stage
- Other
01
Overview
Hybribio is a leading Chinese molecular diagnostics company specializing in in vitro diagnostic (IVD) products for infectious diseases and genetic disorders. Its products are used in over 1,800 hospitals and medical institutes in China and exported to nearly 30 countries. During the COVID-19 pandemic, Hybribio rapidly developed and commercialized two SARS-CoV-2 nucleic acid detection kits, both approved by regulatory authorities and internationally certified. Its HPV diagnostic kits have consistently excelled in WHO external quality assessments, achieving 100% concordance for four consecutive years.
- Therapeutic areas
- Women's HealthInfectious DiseasesRare Diseases
- Modalities
- Nucleic acid diagnostic kitsFluorescence RT-PCRSanger sequencingBiochip technologyGene chip
- Industry
- Molecular Diagnostics
02
Partnerships
University of Hong Kong (technology licensing)
Beyond the preview
Go deeper on Hybribio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hybribio.